John A. Latham, Chief Scientific Officer at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 4,545 shares at $38.94 ($175K) on 2015-09-01, disclosed to the SEC on 2015-09-03.
Scheduled sale ($175k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.41 | 3,645 | $140K | 80.0% |
| 2 | $38.94 | 900 | $35K | 20.0% |
| Total | $38.51 avg | 4,545 | $175K | 100% |
| Filing → |
| ALDR | SELL | 2018-09-06 | $450K | — | Filing → |
| ALDR | SELL | 2018-08-02 | $489K | — | Filing → |
| ALDR | SELL | 2018-07-03 | $387K | — | Filing → |